Cases 1 - 10 of 15
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv00120
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v Mylan Pharmaceuticals Inc.
as 1:2017cv00054
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Alembic Pharmaceuticals Limited v. Novartis AG et al
as 1:2017cv00292
Plaintiff:
Alembic Pharmaceuticals Limited
Defendant:
Novartis AG and Mitsubishi Tanabe Pharma Corporation
Cause Of Action: 35 U.S.C. § 1
Novartis AG et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2016cv00093
Plaintiff:
Novartis AG , Novartis Pharmaceuticals Corporation , Mitsubishi Tanabe Pharma Corporation and others
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Inc. et al
as 1:2014cv00111
Plaintiff:
Novartis Pharmaceuticals Corporation , Novartis Corporation , Novartis AG and others
Defendant:
Mylan Inc. and Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Inc. et al
as 1:2014cv00106
Plaintiff:
Novartis Pharmaceuticals Corporation , Novartis AG , Novartis Pharma AG and others
Defendant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 145
Novartis AG v. Kappos
as 1:2012cv01388
Plaintiff:
Novartis AG
Defendant:
David J. Kappos
Cause Of Action: 35 U.S.C. § 154 AIA Appeal of Patent Term Adjustment Determination
Novartis AG et al v. Kappos
as 1:2012cv00836
Plaintiff:
Novartis AG and Novartis Pharma GmbH
Defendant:
David Kappos
Cause Of Action: 35 U.S.C. § 154
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al
as 1:2011cv00015
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Counter_claimant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_defendant:
Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Clayton v. Sandoz Inc et al
as 1:2010cv00176
Plaintiff:
Donna Clayton
Defendant:
Sandoz Inc , Eon Labs, Inc. , Novartis AG and others
Cause Of Action: 28 U.S.C. § 1441
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
